Analysed IMMUTEP LTD (PRRUF:OTCMKTS) News Sources
Immutep Reports Progress from Phase I Study of LAG-3 Agonist for Autoimmune Diseases
19-03-2026
yahoo.com
Immutep Receives FDA Orphan Drug Designation for Eftilagimod Alfa in Soft Tissue Sarcoma
15-04-2026
yahoo.com
Immutep Limited (IMMP) Receives FDA Orphan Drug Designation for Efti in Soft Tissue Sarcoma
21-04-2026
yahoo.com
Immutep Announces Abstract Accepted for Presentation at the American Society of Clinical Oncology (ASCO) 2026 Annual Meeting
22-04-2026
yahoo.com
What is the current price of IMMUTEP LTD (PRRUF:OTCMKTS)?
The current price of IMMUTEP LTD (PRRUF:OTCMKTS) is $0.05.
IMMUTEP LTD (PRRUF:OTCMKTS) absolute price change since previous trading day?
The absolute price change of IMMUTEP LTD (PRRUF:OTCMKTS) since the previous trading day is $0.
IMMUTEP LTD (PRRUF:OTCMKTS) percentage price change since previous trading day?
The percentage price change of IMMUTEP LTD (PRRUF:OTCMKTS) since the previous trading day is 0%.
What is the most recent average sentiment score for IMMUTEP LTD (PRRUF:OTCMKTS)?
The most recent average sentiment score for IMMUTEP LTD (PRRUF:OTCMKTS) is 66 out of 100.
What is the most recent average sentiment for IMMUTEP LTD (PRRUF:OTCMKTS)?
The most recent sentiment for IMMUTEP LTD (PRRUF:OTCMKTS) is .
SEC-8K** Filing Available For IMMUTEP LTD (PRRUF:OTCMKTS)
** material developments that could impact a company's financial condition or stock price.
Author: MattELab
MattELab is the founder and lead developer of SentientMerchant. With a Computer Science and Quantitative Finance background from a T10 university, he brings over 6 years of expertise in NLP, programmatic SEO, and full-stack development to build highly scalable AI and FinTech solutions.